The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
Last updated
Peptide Profile

Sertraline: Research, Dosing, and Where to Buy in 2026

A research-first profile for Sertraline (Zoloft), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

⚕️ US PRESCRIPTION REQUIRED. Sertraline is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Sertraline is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for Sertraline, each linked to its source.

Key Facts
Pharmaceutical
  • Also indexed as Zoloft.
  • 0 aggregated dosing-protocol mentions from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Sertraline?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Sertraline Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

No transcript-derived dosing mentions in current source set.

Where to Buy Sertraline in 2026

No tracked vendor recommendations for Sertraline yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Sertraline. Each line links to the original source.

  • "After 878 screen failures, 416 participants (mean [SD] age, 37.4 [11.9] years; 310 female [74.5%]) were randomized." · Davis L et al, 2025 PubMed
  • "Completion rates were 137 of 214 participants (64.0%) for brexpiprazole + sertraline and 113 of 202 participants (55.9%) for sertraline + placebo." · Davis L et al, 2025 PubMed
  • "Discontinuation rates due to adverse events were 8 of 205 participants (3.9%) for brexpiprazole + sertraline and 20 of 196 participants (10.2%) for sertraline + placebo." · Davis L et al, 2025 PubMed
  • "The pooled mean differences (MD) in the change in HAM-D total score [MD=-2.34, 95% confidence interval (CI) -2.93, -1.76], CGI-S score and MADRS score, but also the dropout rate for adverse effects, and rate of adverse effects were higher in sertraline group." · Luo X et al, 2023 PubMed

Research and Studies

8 PubMed-indexed papers reference Sertraline. Top 8 shown.

Frequently Asked Questions

Is Sertraline FDA-approved?

Sertraline is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

How much research has been published on Sertraline?

8 PubMed-indexed paper(s) reference Sertraline in our current research feed. See the Research and Studies section above for citations.